SCHEMBL7323222

SCHEMBL7323222

Cn1ccc(-c2cc(OC(F)F)n(-c3ccc([N+](=O)[O-])cc3)n2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ADORA2A P29274 2/20 0.37
NPY5R Q15761 1/20 0.37
PTGS1 P23219 1/20 0.36
HTT P42858 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
IDO1 P14902 1/20 0.35
TDO2 P48775 1/20 0.35
ADORA1 P30542 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327369 0.83 SMN1; SMN2 (0.40) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL7325882 0.81 MEN1 (0.40) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL7326746 0.80 MAPT (0.45) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL7318548 0.78 MAPT (0.40) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL8471864 0.76 MAPT (0.46) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL7316270 0.74 PTGS1 (0.58) MAPTPOLBTDP1PTGS1PTGS2
SCHEMBL12473770 0.67 CA12 (0.46) MAPTRAB9AKMT2APOLBHTT
SCHEMBL9083379 0.65 L3MBTL1 (0.37) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL28397564 0.62 MALT1 (0.45) MAPTPOLBADORA2ANPY5RHTT
SCHEMBL7314318 0.62 USP8 (0.48) MAPTNPC1RAB9AKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 MAPT 2674/4885NPC1 1906/4885RAB9A 4227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.